$0.129800
0.00524.17%
Pre-Market: 8:20 AM EDT
15 minutes delayed
Reshape Lifesciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Reshape Lifesciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $-0.09 | $-0.16 | 43.8 % |
Sep 2023 | 2023-11-08 | $-1.02 | $-1.20 | 15.0 % |
Jun 2023 | 2023-08-07 | $-1.08 | $-1.79 | 39.7 % |
Mar 2023 | 2023-05-15 | $-1.56 | $-4.21 | 62.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $1.97M | $2.21M | -11.1 % |
Mar 2024 | 2024-05-15 | $1.94M | $2.10M | -7.43 % |
Sep 2023 | 2023-11-08 | $2.15M | $2.40M | -10.2 % |
Jun 2023 | 2023-08-07 | $2.25M | $2.61M | -13.6 % |
Reshape Lifesciences (RSLS) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.06, which missed the estimate of $0.00.
The Actual Revenue was $2M, which missed the estimate of $2.2M.
Browse earnings estimates, EPS, and revenue on all stocks.